Brean Capital resumed coverage of Markel (MKL) with a Neutral rating and $2,100 price target The firm believes shares will outperform the S&P 500 over time, but performance in the next 12 months is “less certain” given the numerous changes management has made to shore up profitability in Markel Insurance, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MKL:
- Markel Highlights Strong 2025 Results in Shareholder Letter
- Markel partners with Upfort to enhance protection for U.S. cyber policyholders
- JANA Partners takes new stake in Fiserve, exits position in Trimble
- Markel price target raised to $2,100 from $2,000 at Truist
- Markel Corporation Earnings Call Highlights Strategic Reset